Healthcare - Biotechnology - NASDAQ - US
$ 87.83
-7.63 %
$ 4.75 B
Market Cap
-123.7
P/E
BALANCE SHEET
825 M
ASSETS
340 M
LIABILITIES
485 M
EQUITY
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition
Arcellx, Inc.
| Current Assets | 716 M |
| Cash & Short-Term Investments | 702 M |
| Receivables | 0 |
| Other Current Assets | 14.3 M |
| Non-Current Assets | 109 M |
| Long-Term Investments | 27.2 M |
| PP&E | 69.8 M |
| Other Non-Current Assets | 11.8 M |
| Current Liabilities | 118 M |
| Accounts Payable | 2.62 M |
| Short-Term Debt | 46.8 M |
| Other Current Liabilities | 68.8 M |
| Non-Current Liabilities | 222 M |
| Long-Term Debt | 50.8 M |
| Other Non-Current Liabilities | 171 M |
Balance Sheet
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | |
|---|---|---|---|---|---|---|
| ASSETS | ||||||
| Cash & Cash Equivalents | 394.6 | 64.2 | 104.6 | 46.6 | 34.6 | 14.5 |
| Short Term Investments | 307.4 | 190.7 | 73.8 | 0 | 0 | 0 |
| Receivables | 0 | 0 | 0 | 0 | 0 | 0 |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | 14.3 | 12.0 | 8.2 | 2.8 | 3.5 | 99 K |
| Total Current Assets | 716.4 | 266.9 | 112.8 | 49.4 | 38.1 | 14.6 |
| PP&E | 69.8 | 39.9 | 10.3 | 4.9 | 4.3 | 0.8 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments | 27.2 | 2.5 | 0.2 | 0.2 | 0.1 | 0 |
| Other Long Term Assets | 11.8 | 4.6 | 5.5 | 3.2 | 1.1 | 0.4 |
| Other Assets | 1 | 0 | 0 | 0 | 0 | 0 |
| Total Assets | 825.1 | 313.8 | 128.8 | 57.7 | 43.6 | 15.8 |
| LIABILITIES | ||||||
| Accounts Payable | 2.6 | 9.1 | 1.3 | 0.5 | 1.7 | 1.1 |
| Short Term Debt | 46.8 | 36.0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 18.3 | 11.7 | 13.5 | 4.8 | 1.3 | 0.8 |
| Total Current Liabilities | 118.2 | 56.7 | 14.8 | 5.3 | 3.0 | 1.8 |
| Long Term Debt | 50.8 | 52.2 | 0 | 0 | 0 | 0 |
| Deferred Tax Income | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Liabilities | 0 | 0 | 235.5 | 116.1 | 73.3 | 0 |
| Total Liabilities | 339.8 | 108.9 | 250.3 | 121.4 | 76.3 | 1.8 |
| EQUITY | ||||||
| Common Stock | 52 K | 44 K | 1 K | 1 K | 1 K | 1 K |
| Retained Earnings | (389.5) | (318.8) | (130.1) | (65.1) | (33.0) | (15.1) |
| Other Accumulative Comprehensive Income/Loss | 0.5 | (0.2) | 20 K | (114.3) | (71.5) | 0 |
| Total Equity | 485.4 | 205.0 | (121.5) | (63.7) | (32.7) | 14.0 |
| Total Liabilities and Equity | 825.1 | 313.8 | 128.8 | 57.7 | 43.6 | 15.8 |
| SHARES OUTSTANDING | ||||||
| Common Shares Outstanding | 48.1 | 44.1 | 35.7 | 33.5 | 34.8 | 0.2 |